Journal Home
Search for

Volume 93, Issue 3, Pages 530-533 (December 2009)


View previous. 28 of 52 View next.

A study of middle ear function in the treatment of nasopharyngeal carcinoma with IMRT technique

Sheng Zi WangaCorresponding Author Informationemail addressemail address, Ji Lia, Curtis T. Miyamotob, Fu Chena, Li Fen Zhoua, Hai Yan Zhanga, Gang Yanga, Wei Fang Wanga, Ming Guoa, Xiao Chen Nia, Lei Wanga

Received 26 October 2008; received in revised form 16 September 2009; accepted 29 September 2009. published online 23 October 2009.

Abstract 

Purpose

This study evaluates the difference in damage to middle ear function with CRT and IMRT techniques in the treatment of nasopharyngeal carcinoma (NPC). We explore the isthmus of the Eustachian tube (ET) as the key anatomic site for the prevention of radiation-induced otitis media with effusion.

Methods and materials

Eighty-two patients with NPC were divided into two groups: 40 patients treated with CRT and 42 patients treated with IMRT. The difference between dosage over the middle ear cavity and the isthmus of the ET was evaluated in both CRT group and IMRT group. All patients underwent hearing tests including pure tone audiometry and impedance audiometry before and after RT.

Results

The dosage difference to the middle ear cavity and isthmus between these two groups was statistically significant (p<0.05). The difference in hearing test results between these two groups was also statistically significant (p<0.05). If we limited the dose to the middle ear cavity under 34Gy and the dose to the isthmus under 53Gy with IMRT, we may decrease radiation-induced OME even with the larger 2.25Gy fraction size.

Conclusions

IMRT may have better protected the middle ear function compared with the CRT technique, even with larger fraction sizes than for the conventional CRT technique.

a Department of Radiation Oncology, Eye, Ear, Nose and Throat Hospital of Fudan University, Shanghai, China

b Department of Radiation Oncology, Temple University Hospital, USA

Corresponding Author InformationCorresponding author. Address: Department of Radiation Oncology, Eye, Ear, Nose and Throat Hospital of Fudan University, Shanghai 200031, China.

PII: S0167-8140(09)00561-1

doi:10.1016/j.radonc.2009.09.013


View previous. 28 of 52 View next.